 | Oxford–AstraZeneca COVID-19 vaccine (redirect from Azd1222) vaccine AZD1222, SII Covishield, SK Bioscience) (Guidance). World Health Organization. 21 April 2021. WHO/2019-nCoV/vaccines/SAGE_recommendation/AZD1222/2021... 211 KB (16,862 words) - 19:31, 11 March 2024 |
 | people who had previously received the Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the... 51 KB (5,052 words) - 19:27, 11 March 2024 |
people who had previously received the Oxford–AstraZeneca COVID‑19 vaccine (AZD1222) during the COVID‑19 pandemic. It was subsequently also described in the... 192 KB (21,930 words) - 19:29, 15 April 2024 |
multinational pharmaceutical company AstraZeneca, which is developing AZD1222 (Covishield) in partnership with the University of Oxford. It is reported... 19 KB (1,601 words) - 21:04, 11 February 2024 |
 | Modified chimpanzee adenovirus viral vector $1.2 billion May 21, 2020 AZD1222 No FDA authorization. First authorized December 20, 2020, in the United... 72 KB (5,994 words) - 15:49, 8 February 2024 |
 | the Treaty on Open Skies. November 23 – COVID-19 pandemic: AstraZeneca's AZD1222 vaccine, developed in collaboration with Oxford University, is shown to... 234 KB (19,223 words) - 08:08, 16 April 2024 |
 | Oxford University and AstraZeneca would begin in July 2020. One of them, AZD1222, reached phase III trials. On 23 November 2020, Oxford–AstraZeneca announced... 85 KB (7,811 words) - 21:10, 17 April 2024 |
used in the manufacturing of the Oxford–AstraZeneca COVID-19 vaccine (AKA AZD1222). The cells are filtered out of the final products. Regeneron Pharmaceuticals... 25 KB (3,065 words) - 11:40, 29 March 2024 |
 | global trial. Convidecia is similar to other viral vector vaccines like AZD1222, Gam-COVID-Vac, and Ad26.COV2.S. Its single-dose regimen and normal refrigerator... 36 KB (3,379 words) - 00:52, 31 December 2023 |
 | Innovations. Gilbert delivered an update in September 2020 that the vaccine, AZD1222, was being produced by AstraZeneca while phase III trials were ongoing... 26 KB (2,706 words) - 19:36, 11 December 2023 |